Thus, MRI PEER evaluation may be most relevant for guiding the management of CD117 + oncocytic tumours, but further evaluation is needed to determine whether it is useful for guiding the management of CD117‐ oncocytic tumours. The gene discussed is KIT; the disease is oncocytic neoplasm.